ELECTROPHYSIOLOGICAL INDICATORS OF INFLUENCE OF TRANSCRANIAL MAGNETIC STIMULATION ON OPIOID DEPENDENCE TREATMENT
PDF

How to Cite

თოდაძე ხ. T. K., ზაქარაია მ. Z. M., & ლეჟავა გ. L. G. (2019). ELECTROPHYSIOLOGICAL INDICATORS OF INFLUENCE OF TRANSCRANIAL MAGNETIC STIMULATION ON OPIOID DEPENDENCE TREATMENT. Collection of Scientific Works of Tbilisi State Medical University, 49, 62–64. https://doi.org/10.52340/csw.2015.49.0.62-64

Abstract

Transcranial Magnetic Stimulation (TMS) is a relatively novel therapeutic and diagnostic tool. It was successfully used for the treatment of various pathologies. Data exists that TMS is sufficiently effective as mono therapy and along with treatment with different pharmaceuticals, also. Clinical research of the influence of low intensity, high frequency magnetic fields with the help of original magnetic stimulator was launched at the Georgian Research Institute on Addiction. Stimulation with low intensity magnetic fields is safe, and allows for the modification of the parameters of stimulation and therapeutic use in a relatively wide range.  420 patients suffering from opioid addiction take part in the research.  Results may be summarized as follows: The high frequency, low intensity magnetic therapy in combination with conventional pharmacotherapy causes reliable improvement in coparision with standard treatment and placebo. Changes are more obvious in the spectral component of the bioelectric activity; examination of the brain electrical activity with various methods (EEG, frequency spectra and evoked potentials) enables us to suppose that observed results are caused by positive changes in metabolic activity; TMS improved effectiveness of traditional treatment and permits to diminish or entirely stop use of psychotropic medications on the late stage of treatment.

https://doi.org/10.52340/csw.2015.49.0.62-64
PDF

References

1. Lezhava, G.; Daraselia D.; Papuashvili N.; Zakharaia M.; TodadzeKh.,Shakharishvili R. (2003).Official Bulletin of the industrial property,Device for electromagnitotherapy of brain diseases. 17(141), Tbilisi, pp. 9-10.
2. Berardelli, Ighilleri, M., Cruccu, G., Fornarelli, M., Accornero, N., Manfredi, M. Stimulation of motor tracts in multiple sclerosis. //J. Neurol. Neurosurg. Psychiatry, 1988, 51:51677-683
3. Ballamoli E., Mangano P., Schvartz R.P., rTMS in the treatment of drug addiction: An update about human studies. Behavioral Neurology, 2014.Published online 2014.
4. Caramia, M.D., Rossini PM. Evaluation of human central pathways by magnetic stimulation: characterisation of conductivity and excitability in a clinical context. //In: Magnetic stimulation in Clinical Neurophysiology. Ed.: B. Choroverty, Pub: Butterworth, p. 249-274
5. Evans, B.A., Litchy W.J., Daube J.R. //The utility of magnetic stimulation for routine peripheral nerve conduction studies. Muscle and nerve, 1988, 10:1074-1078
6. George, M.S., Wassermann E.M. & Post, R.M. Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century. // J.Neuropsychiatry Clin.Neurisci., 1996, ¹8, P 373-382
7. George M.S., Belmaker R.H., - Transcranial magnetic stimulation in Clinical Psychiatry, 2006;
8. Kahkonen S., Welenius J., Nikulin V.V. Ethanol modulated cortical activity: direct evidence with combined TMS and EEG. Neuroimage; 2001 14(2): 322-328.
9. Maria D. Majewska,, David Thoms,. Transcranial Magnetic Stimulation in the Treatment of Drug Abuse and Other Brain Disorders, Report of conference, BethesdaBethesda, March 16, 2004
10. Pascual-Leone,A., Rubio, B., Pallardo, F & Catala, M.D. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug resistant depression, / /Lancet, 1996, ¹348, P 233-237.
11. SchaepferTh.E., Kosel, M., Nemeroff Ch.B.Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders. // Neuropsychopharmacology, 2003, 28, p. 201-205.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...